Procter & Gamble Company filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
$PG
Package Goods/Cosmetics
Consumer Discretionary
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): October 8, 2024
(Exact Name of Registrant as Specified in Its Charter)
|
|
|
|||
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number) |
(I.R.S. Employer Identification No.)
|
(Address of principal executive offices, including zip code)
(Registrant’s telephone number, including area code)
(Former name or former address, if changed
since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange on which registered
|
||
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act
of 1934 (§240.12b-2 of this chapter).
|
||
|
|
|
Emerging growth company
|
|
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ |
||
ITEM 7.01 REGULATION FD DISCLOSURE
On October 8, 2024, The Procter & Gamble Company (the "Company") announced that its Board of Directors declared a quarterly dividend of $1.0065 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after November 15, 2024, to Common Stock shareholders of record at the close
of business on October 18, 2024, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on October 18, 2024.
The Company is furnishing this 8-K pursuant to Item 7.01, "Regulation FD Disclosure."
|
ITEM 9.01 FINANCIAL STATEMENTS AND
EXHIBITS
|
(d) Exhibits
|
Exhibit Number
|
|
Description
|
|
99.1
|
|
Dividend News Release by The Procter & Gamble Company dated October 8, 2024.
|
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
THE PROCTER & GAMBLE COMPANY
|
|
|
|
|
|
|
|
BY: /s/ Sandra T. Lane |
| Sandra T. Lane |
||
| Assistant Secretary |
||
| October 8, 2024 |
INDEX TO EXHIBIT(S)
|
Exhibit Number
|
|
Description
|
|
|
|